Brevan Howard Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.53M Buy
21,574
+18,212
+542% +$4.58M 0.04% 267
2025
Q4
$956K Buy
3,362
+267
+9% +$83.5K 0.01% 792
2025
Q3
$956K Buy
3,095
+2,050
+196% +$642K ﹤0.01% 922
2025
Q2
$328K Buy
+1,045
New +$302K ﹤0.01% 1512
2025
Q1
Sell
-1,168
Closed -$305K 1393
2024
Q4
$305K Buy
+1,168
New +$294K ﹤0.01% 769
2024
Q3
Sell
-2,576
Closed -$520K 1370
2024
Q2
$520K Sell
2,576
-693
-21% -$125K ﹤0.01% 592
2024
Q1
$560K Sell
3,269
-1,323
-29% -$247K 0.01% 422
2023
Q4
$996K Buy
4,592
+3,215
+233% +$551K 0.01% 235
2023
Q3
$220K Buy
+1,377
New +$308K ﹤0.01% 309

Other funds holding PODD

Brevan Howard Capital Management's PODD Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Insulet (PODD) stake by 542% in Q1 2026, buying an estimated $4.58M and bringing the position to 21,574 shares worth $4.53M. The position accounts for 0.04% of the portfolio, ranked #267.

Brevan Howard Capital Management first reported a position in PODD in Q3 2023 and has held it in 9 quarters since. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Brevan Howard Capital Management held 21,574 shares of Insulet worth $4.53M as of Q1 2026.
  • Brevan Howard Capital Management bought 18,212 Insulet shares in Q1 2026, an estimated $4.58M.
  • Insulet made up 0.04% of Brevan Howard Capital Management's portfolio in Q1 2026, its #267 holding.
  • Brevan Howard Capital Management first reported a position in Insulet in Q3 2023 and has held it in 9 quarters since.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.